Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the control GAPDH western blotting bands shown in Fig. 4H on p. 496 were strikingly similar to data that were submitted for publication in advance of this article in different form by different authors at different research institutes [Liu F, Bai C and Guo Z: The prognostic value of osteopontin in limited‑stage small cell lung cancer patients and its mechanism. Oncotarget 8: 70084‑70096, 2017]. A further independent investigation conducted in the Editorial Office revealed that other western blotting data were likely to have been shared in common, comparing between the two articles. Owing to the fact that the contentious data in the above article had already been submitted for publication prior to the submission of this article to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, it was admitted that the authors Feng Chang, Jian-Na Liu and Jun-Xin Lin did not initially provide their agreement to be authors on this paper; otherwise, the rest of the authors accepted the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 39: 491‑500, 2018; DOI: 10.3892/or.2017.6142].

[Retracted] miR‐34a is downregulated in human osteosarcoma stem‐like cells and promotes invasion, tumorigenic ability and self‐renewal capacity

[Retracted] miR‐17‐5p promotes the growth of osteosarcoma in a BRCC2‐dependent mechanism

[Retracted] Upregulation of Microrna‑25‑3p Inhibits Proliferation, Migration and Invasion of Osteosarcoma Cells in Vitro by Directly Targeting SOX4.

[Retracted] MicroRNA‑505 is downregulated in human osteosarcoma and regulates cell proliferation, migration and invasion

[Retracted] MicroRNA‑874 Inhibits Growth, Induces Apoptosis and Reverses Chemoresistance in Colorectal Cancer by Targeting X‑linked Inhibitor of Apoptosis Protein

[Retracted] miR‐133b induces chemoresistance of osteosarcoma cells to cisplatin treatment by promoting cell death, migration and invasion

[Retracted] MicroRNA‑132 inhibits cell growth and metastasis in osteosarcoma cell lines possibly by targeting Sox4

Microrna-336 Directly Targets Sox-2 in Osteosarcoma to Inhibit Tumorigenesis

[Retracted] MicroRNA‐320 targets mitogen‐activated protein kinase 1 to inhibit cell proliferation and invasion in epithelial ovarian cancer

[Retracted] MicroRNA‐34a expression affects breast cancer invasion in vitro and patient survival via downregulation of E2F1 and E2F3 expression

[Retracted] microRNA‐206 overexpression inhibits cellular proliferation and invasion of estrogen receptor α‐positive ovarian cancer cells

[Retracted] MicroRNA‐329‐3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer

[Retracted] Downregulation of microRNA-206 suppresses clear cell renal carcinoma proliferation and invasion by targeting vascular endothelial growth factor A

[Retracted] Inhibiting Proliferation and Migration of Lung Cancer Using Small Interfering RNA Targeting on Aldo‑keto Reductase Family 1 Member B10.

[Retracted] MicroRNA‐655 suppresses cell proliferation and invasion in oral squamous cell carcinoma by directly targeting metadherin and regulating the PTEN/AKT pathway

RETRACTION: Inhibition of microRNA-940 suppresses the migration and invasion of human osteosarcoma cells through the secreted frizzled-related protein 1-mediated Wnt/-catenin signaling pathway (Retraction of Vol 120, Pg 2657, 2019)

[Retracted] Effects of Grb2‐associated binding protein 2‐specific siRNA on the migration and invasion of MG‐63 osteosarcoma cells

[Retracted] MicroRNA‐219 is downregulated in non‐small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2

[Retracted] MicroRNA‐140 represses glioma growth and metastasis by directly targeting ADAM9

Retracted: CircEIF4G2 Promotes Tumorigenesis and Progression of Osteosarcoma by Sponging miR-218

[Retracted] lncRNA ROR promotes the progression of renal cell carcinoma through the miR‐206/VEGF axis